Key Eligibility Criteria for This Study

To be eligible for the study, the patient must

  • Be at least 18 years of age
  • Have a documented history of at least 2 previous episodes of Clostridium difficile infection in the last 2 months and currently experiencing an active C. diff infection

Study participation will also depend on other requirements which will be determined at the screening visit.

Can I Take Part?


  • Seres Therapeutics (Study Protocol, 20170324 Poster English20170324V1SERES-012RecruitmentBrochureEnglishCMcG, Seres 012PosterEnglish CLIENT REV & QD TRKED.DOCX)